Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ardsley Partners is a Stamford, Connecticut-based investment management firm operating through Ardsley Advisory Partners. The firm is primarily a long/short equity hedge fund manager with sector exposure that includes healthcare, biotechnology, technology, and clean energy. Although it runs healthcare-focused investment vehicles, it is not a drug developer, biotechnology company, pharmaceutical company, or healthcare services operator. Its business is investment management rather than the discovery, development, manufacture, or commercialization of therapeutic products. For biotech analysts, Ardsley is best understood as a sector-focused financial investor with activity in healthcare and life sciences equities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ardsley Partners.